skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All


Show More


Show More

Information Types

Show More


Show More

Show More

Product Listing

4 product(s) and free and sample content

From: Datamonitor Healthcare

Datamonitor Healthcare

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

  • Prioritize market opportunities
  • Identify unmet needs
  • Make informed decisions

Datamonitor Healthcare

Immuno-Oncology Overview

By Colin White, Robert Jeng & Jolene Lau 26 Oct 2016

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well

Topic immuno-oncology

Datamonitor Healthcare

Profitability Assessment of Branded Generic Inhalers

By Ljlal Syed, Mark Lansdell and David Abramson 20 Oct 2016

This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic

Topic Deal trends

From: Trialtrove


The industry’s gold standard for clinical trials intelligence, made by experts for experts

  • ​Robust, curated content
  • Clinical trial landscape
  • Standard of care insights


What is new for refractory asthma therapies?

By Laura Runkel 09 Jan 2017

The past year has seen the approval of the first biologic drugs for the treatment of severe eosinophilic asthma, the anti-IL5 antibodies Cinquar (Teva) and Nucala (GlaxoSmithKline, GSK).

Topic Clinical trials Drug approval Clinical trial optimization


IL-6: Vying for a Sliver of the Rheumatoid Arthritis Pie

By Pamela Spicer 19 Dec 2016

TNF antagonists have played a major role in rheumatoid arthritis (RA) prescribing trends, even helping to make adalimumab (Humira) and etanercept (Enbrel) rank among the top selling products.

Topic Arthritis

From: Biomedtracker


Track and assess key events that will impact a drug’s probability of technical success and approval.

  • Stay up to date in an ever changing industry
  • Get ahead of the competition
  • Skip the travel and stay informed


Finding Finance: Pharma, Biotech & Medtech Capital Raising 2016

23 Mar 2017

There is no doubt that 2016 will be marked as year of surprising results. None more so than how life science companies fared in the capital markets.

Topic Business strategies


Healthcare Conference BioMedTracker - Day 3

11 Aug 2016

The 34th annual JP Morgan Healthcare Conference is being held in San Francisco, CA from January 11- 14, 2016

Topic Clinical trial optimization

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: